1. Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. (23rd August 2018) Authors: Kron, A; Alidousty, C; Scheffler, M; Merkelbach-Bruse, S; Seidel, D; Riedel, R; Ihle, M A; Michels, S; Nogova, L; Fassunke, J; Heydt, C; Kron, F; Ueckeroth, F; Serke, M; Krüger, S; Grohe, C; Koschel, D; Benedikter, J; Kaminsky, B; Schaaf, B Journal: Annals of oncology Issue: Volume 29:Number 10(2018) Page Start: 2068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗